Related Experiment Video
Updated: May 5, 2026

10:37
Fabrication of 3D Cardiac Microtissue Arrays using Human iPSC-Derived Cardiomyocytes, Cardiac Fibroblasts, and Endothelial Cells
Published on: March 14, 2021
6.5K
Design and formulation of functional pluripotent stem cell-derived cardiac microtissues
Nimalan Thavandiran1, Nicole Dubois, Alexander Mikryukov
1Institute for Biomaterials and Biomedical Engineering, University of Toronto, Toronto, ON, Canada M5S 3G9.
Summary
Researchers developed cardiac microwires (CMWs), advanced 3D human cardiac tissue models, using computational modeling and microfabrication. These CMWs improve drug testing for heart disease by mimicking in vivo function and enabling higher-throughput analysis.
Area of Science:
- Biomedical Engineering
- Stem Cell Biology
- Cardiovascular Research
Background:
- Developing accurate human cardiac tissue models is crucial for advancing heart disease drug discovery.
- Existing 3D models often struggle to replicate adult-like tissue fidelity and function.
- Human pluripotent stem cell (hPSC)-derived tissues offer potential but require optimized engineering.
Purpose of the Study:
- To engineer functional, aligned 3D cardiac microtissues (cardiac microwires, CMWs) using hPSCs.
- To optimize CMWs for enhanced maturation, electrical signal propagation, and drug responsiveness.
- To establish a predictive in vitro platform for cardiac electrophysiology and drug screening.
Main Methods:
- Utilized computational modeling of tissue mechanics to guide microtissue design.
- Employed microfabricated constraints for controlled self-assembly of hPSC-derived cardiac cells.
- Applied electromechanical stimuli, including aligned collagen and point stimulation pacing.
- Screened varying ratios of cardiomyocytes (NKX2-5+) and nonmyocytes (CD90+) for optimal tissue properties.
Main Results:
- Engineered aligned and functional cardiac microwires (CMWs) from hPSCs.
- Demonstrated that electromechanical stimuli and specific cell compositions enhance cardiac maturation.
- Identified an optimal ratio of 75% NKX2-5+ cardiomyocytes and 25% CD90+ nonmyocytes for superior tissue properties.
- Successfully modeled arrhythmogenesis in a tachycardic context, a feat not previously achieved in similar 3D models.
Conclusions:
- The cardiac microwire platform provides a high-fidelity, miniaturized model for human cardiac tissue.
- Optimized CMWs exhibit improved structural and functional properties, including in vivo-like electrical propagation.
- This platform accelerates the development of predictive in vitro assays for heart disease drug discovery and electrophysiology studies.
Keywords:
arrhythmia disease modelcardiac toxicityheart regenerationmicrofabricationtissue engineering
